Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427.
N Engl J Med. 2017.
PMID: 28076709
Free PMC article.
Clinical Trial.